Androgen deprivation therapy and cardiovascular risk in patients with prostate cancer

Type of androgen deprivation therapy and the risk of cardiovascular diseases in patients with prostate cancer with or without pre-existing cardiovascular risk

European Urology ◽

10.1016/s0302-2838(21)01224-0 ◽

2021 ◽

Vol 79 ◽

pp. S1187

Author(s):

A. Dragomir ◽

N. Touma ◽

A.P. Aprikian

Keyword(s):

Prostate Cancer ◽

Cardiovascular Risk ◽

Cardiovascular Diseases ◽

Low Serum Testosterone in Men With Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors—A Radical PC Substudy

The Journal of Urology ◽

10.1097/ju.0000000000002384 ◽

2022 ◽

Author(s):

Jehonathan H. Pinthus ◽

Wilhelmina C. M. Duivenvoorden ◽

Laurence Klotz ◽

Som D. Mukherjee ◽

Robert Siemens ◽

...

Keyword(s):

Prostate Cancer ◽

Risk Factors ◽

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Serum Testosterone ◽

Androgen Deprivation ◽

Newly Diagnosed ◽

Low Serum

Mortality, cardiovascular risk, and androgen deprivation therapy for prostate cancer

Medicine ◽

10.1097/md.0000000000003873 ◽

2016 ◽

Vol 95 (24) ◽

pp. e3873 ◽

Cited By ~ 14

Author(s):

Lucie-Marie Scailteux ◽

Florian Naudet ◽

Quentin Alimi ◽

Sébastien Vincendeau ◽

Emmanuel Oger

Keyword(s):

Prostate Cancer ◽

Cardiovascular Risk ◽

Cardiovascular risk after androgen deprivation therapy for prostate cancer: an Asian perspective

International Urology and Nephrology ◽

10.1007/s11255-016-1337-5 ◽

2016 ◽

Vol 48 (9) ◽

pp. 1429-1435 ◽

Cited By ~ 3

Author(s):

Jeremy Yuen Chun Teoh ◽

Chi-Fai Ng

Keyword(s):

Prostate Cancer ◽

Cardiovascular Risk ◽

PCN8 The Association Between Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk in Taiwan: A Population-Based Cohort Study

Value in Health ◽

10.1016/j.jval.2012.08.306 ◽

2012 ◽

Vol 15 (7) ◽

pp. A654

Author(s):

Y.H. Tsai ◽

T.R. Tsai

Keyword(s):

Prostate Cancer ◽

Cohort Study ◽

Cardiovascular Risk ◽

Population Based ◽

Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non-metastatic prostate cancer: implementation of standardized management guidelines

Andrology ◽

10.1111/j.2047-2927.2013.00093.x ◽

2013 ◽

Vol 1 (4) ◽

pp. 583-589 ◽

Cited By ~ 27

Author(s):

A. S. Cheung ◽

D. Pattison ◽

I. Bretherton ◽

R. Hoermann ◽

D. Lim Joon ◽

...

Keyword(s):

Prostate Cancer ◽

Cardiovascular Risk ◽

Bone Loss ◽

Metastatic Prostate Cancer ◽

Androgen Deprivation ◽

Management Guidelines

Cardiovascular risk during androgen deprivation therapy for prostate cancer

BMJ ◽

10.1136/bmj.d3105 ◽

2011 ◽

Vol 342 (may24 2) ◽

pp. d3105-d3105 ◽

Cited By ~ 12

Author(s):

T. H. Jones

Keyword(s):

Prostate Cancer ◽

Cardiovascular Risk ◽

PD09-11 CARDIOVASCULAR RISK FACTORS FOR PATIENTS WITH ADVANCED PROSTATE CANCER ON ANDROGEN DEPRIVATION THERAPY

The Journal of Urology ◽

10.1097/ju.0000000000000836.011 ◽

2020 ◽

Vol 203 ◽

pp. e178-e179

Author(s):

Zoe Gan* ◽

Raju Chelluri ◽

Leilei Xia ◽

anisleidy Fombona ◽

Thomas Guzzo ◽

...

Keyword(s):

Prostate Cancer ◽

Risk Factors ◽

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Advanced Prostate Cancer ◽

Cardiovascular risk and androgen deprivation therapy for prostate cancer: systematic review and meta-analysis of randomised controlled trials and observational studies (METADTCR)

Clinical Therapeutics ◽

10.1016/j.clinthera.2015.05.017 ◽

2015 ◽

Vol 37 (8) ◽

pp. e3

Author(s):

L.-M. Scailteux ◽

F. Naudet ◽

Q. Alimi ◽

S. Vincendeau ◽

E. Oger

Keyword(s):

Prostate Cancer ◽

Systematic Review ◽

Cardiovascular Risk ◽

Observational Studies ◽

Randomised Controlled Trials ◽

Meta Analysis ◽

Androgen Deprivation ◽

Controlled Trials ◽

Randomised Controlled

Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk

Circulation ◽

10.1161/circulationaha.109.192695 ◽

2010 ◽

Vol 121 (6) ◽

pp. 833-840 ◽

Cited By ~ 189

Author(s):

Glenn N. Levine ◽

Anthony V. D'Amico ◽

Peter Berger ◽

Peter E. Clark ◽

Robert H. Eckel ◽

...

Keyword(s):

Prostate Cancer ◽

Cardiovascular Risk ◽